About Klang Hospital
Bangkok Metropolitan Administration General Hospital, popularly known as Klang Hospital is a public tertiary hospital in Thailand located on corner of the Luang and Suea Pa Roads, Pom Prap Subdistrict, Pom Prap Sattru Phai District, Bangkok.
There are 500 beds in Klang Hospital.
Clinical Trials at Klang Hospital
During the past decade, Klang Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klang Hospital"
#1 collaborator was "Bhumibol Adulyadej Hospital" with 2 trials as a collaborator, "Klang Hospital" with 2 trials as a collaborator, "Navitas Life Sciences GmbH" with 2 trials as a collaborator, "Bamrasnaradura Infectious Diseases Institute" with 1 trials as a collaborator and "Buddhachinnaraj Hospital" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Klang Hospital
According to Clinical.Site data, the most researched conditions in "Klang Hospital" are
"HIV-infected Participants With Latent TB Infection in High TB Burden Country" (1 trials), "HIV/TB Coinfection" (1 trials), "Renal Anaemia" (1 trials) and "Renal Anemia" (1 trials). Many other conditions were trialed in "Klang Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Klang Hospital
Most popular intervention types in "Klang Hospital" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "EPIAO®" (2 trials), "EPREX®" (2 trials), "DTG 50 mg BID" (1 trials), "DTG 50 mg OD with food" (1 trials) and "Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klang Hospital
The vast majority of trials in "Klang Hospital" are
4 trials for "All" genders.
Clinical Trials Status at Klang Hospital
Currently, there are NaN active trials in "Klang Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klang Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klang Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".